本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Recursion Pharmaceuticals, Inc.

5.32
-0.5900-9.98%
盤後5.13-0.1894-3.56%19:59 EDT
成交量:6,053.03萬
成交額:3.41億
市值:23.10億
市盈率:-2.95
高:6.20
開:6.04
低:5.30
收:5.91
52周最高:12.36
52周最低:3.79
股本:4.34億
流通股本:4.15億
量比:1.15
換手率:14.59%
股息:- -
股息率:- -
每股收益(TTM):-1.8042
每股收益(LYR):-1.6909
淨資產收益率:-86.34%
總資產收益率:-39.08%
市淨率:2.51
市盈率(LYR):-3.15

資料載入中...

2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/06

重要事件披露

Form 8-K - Current report
2024/07/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/08

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/27

關聯方擬減持公告

Form144 | Recursion Pharmaceuticals高管Tina Marriott擬減持6000股,總價約43290美元
2024/06/27

重要事件披露

Form 8-K - Current report
2024/06/25

關聯方擬減持公告

Form144|Recursion Pharmaceuticals公司董事Blake Borgeson擬減持11447股,總價約108.8萬美元
2024/06/24

重要事件披露

Form 8-K - Current report
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/13

SEC問詢函

Form CORRESP - Correspondence
2024/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities